Pharmaceutical company Mylan (Berlin: 6MY.BE - news) said Tuesday that it would take its offer to buy Perrigo directly to Perrigo shareholders following refusals by the company's management to engage in merger talks. Mylan, a large generic drugs company, will launch the offer to Perrigo shareholders on Monday and Perrigo shareholders will be eligible to vote until November 13. Perrigo makes over-the-counter medications such as Claritin and Sudafed. Mylan has proposed $75 in... More